In this dynamic presentation Dr. Mimi Secor DNP, FNP-BC, FAANP, FAAN, presents current challenges and trends in contraceptive management in 2024. Learners will understand medical eligibility criteria and the latest contraceptive research for prescribing considerations. Unique patient considerations, efficacy, patient needs, and other critical prescribing points are reviewed. | 1.50 credits (1.50 Pharmacology) | $40

This presentation will explore the physiology behind vasomotor symptoms in menopause in preparation for introducing pharmacologic management. An analysis of various pharmaceutical interventions including FDA approved, off-label use, OTC, and varying guideline recommendations will be performed. | 1.50 credits (1.0 Pharmacology) | $40

In this Friends of NPACE Podcast live recording, Women’s health expert Alison Marshall provides insight into what is occurring in both vaginitis and STIs in the U.S. and why this matters to primary care providers. Listeners will leave with an increased understanding of the current state of both and important keys to screening and diagnosis. Credits: 0.50 contact hours; 0.00 are pharmacology

Cervical cancer prevention has changed significantly in recent years with less frequent screening and with the approval of HPV primary screening every 5 years, with a reflex Pap done only if the HPV test is positive. Additionally, cotesting with Pap and HPV every 5 years or Pap alone every 3 years remains an option. This session will review the appropriate use of Pap testing, the rationale for HPV testing along with the Pap (co-testing) in women 30 and older and the use of HPV testing as a primary screen (stand-alone test) in women 25 and older by two of the FDA approved HPV tests. There will be a discussion of the American Cancer Society Guidelines for screening and a review of the 2019 ASCCP Risk-Based Management Consensus Guidelines for management of abnormal screening and subsequent follow-up with case studies. These guidelines are a shift from results-based to risk-based management relative to the risk of an existing CIN 3 (pre-cancer). | 1.0 credits (0 Pharmacology) | $27.50

This presentation is foundational to an understanding of female health, particularly as it relates to female sexual development and women’s health needs relating to sexual health across the lifespan. This presentation will review the NPs role in guiding their patients through normal female sexual development. Particular focus will be paid to patient education, counseling, and dispelling of myths. Also, to be reviewed is the most up to date sexual history techniques to ensure that providers are inclusive and complete in their data collection.​ |1.0 credits (0.25 Pharmacology) | $30

This presentation will review the increasing prevalence of syphilis, including which populations of patients should be tested for this infection. The syphilis testing cascade will be discussed, including guidance on how to ensure that an active infection has been completely treated and how often patients need follow-up and tests of reinfection. The current penicillin shortage will be discussed when the most appropriate, evidenced-based treatment |1.0 credits (0.50 Pharmacology) | $30